Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 74, Issue 6, Pages 1105-1111Publisher
SPRINGER
DOI: 10.1007/s00280-014-2559-9
Keywords
MicroRNA; Cancer; Lung; Biomarker
Categories
Ask authors/readers for more resources
Lung cancer as a malignance has been killing numerous patients around the world annually, and small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are the two major types, the later accounting for nearly 80 % of lung cancer. There are multiple causes for lung cancer, and more researches have been carried out to prevent, anticipate, and diagnose the cancer. MicroRNAs (miRNAs) are small non-coding RNA molecules capable of regulating expression of over 50 % of protein-coding genes. The RNA molecules are stable in tissues and blood, so it can tend to be a biomarker in anti-lung cancer. Here, this is a review on the roles of miRNAs for possible ways to prevent lung cancer in clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available